Abstract：
BACKGROUND: Eye care and assessment of the eye are critical for intensive care patients to prevent ocular complications like dry eye and corneal abrasion. However, there is no measurement tool developed for intensive care patients that examines the risks of ocular complications.
OBJECTIVE: This study aimed to develop a valid and reliable tool, the Critically Ill Patient Eye Assessment Scale (CIPEAS), for assessing the risk of ocular complications and determining the frequency of eye care.
METHODS: This study is an instrument development study. This methodological study was conducted with 151 intensive care patients in Turkey between March 2022 and March 2023. Data were collected with the Patient Information Form and the CIPEAS. The data were evaluated using SPSS 23 statistical software. AMOS 21 was used to verify the structure obtained with CFA. Exploration and confirmatory factor analyses were performed to determine the scale\'s factorial structure.
RESULTS: As a result of exploratory factor analysis, a six-item scale consisting of a single dimension was obtained, explaining 59.993% of the total variance. The fit indices of the scale were found to be χ2/SD = 2.653, GFI = 0.954, RMSEA = 0.075, NFI = 0.949 and CFI = 0.967. Cronbach\'s alpha of the scale was found to be 0.862.
CONCLUSIONS: The CIPEAS was found to be a valid and reliable assessment tool.
CONCLUSIONS: The Critically Ill Patient Eye Assessment Scale is a valid and reliable tool for Turkish society for assessing the risk of ocular complications. It is recommended for various national and international studies with different patients in intensive care units.
OBJECTIVE: This study aimed to develop a valid and reliable tool, the Critically Ill Patient Eye Assessment Scale (CIPEAS), for assessing the risk of ocular complications and determining the frequency of eye care.
METHODS: This study is an instrument development study. This methodological study was conducted with 151 intensive care patients in Turkey between March 2022 and March 2023. Data were collected with the Patient Information Form and the CIPEAS. The data were evaluated using SPSS 23 statistical software. AMOS 21 was used to verify the structure obtained with CFA. Exploration and confirmatory factor analyses were performed to determine the scale\'s factorial structure.
RESULTS: As a result of exploratory factor analysis, a six-item scale consisting of a single dimension was obtained, explaining 59.993% of the total variance. The fit indices of the scale were found to be χ2/SD = 2.653, GFI = 0.954, RMSEA = 0.075, NFI = 0.949 and CFI = 0.967. Cronbach\'s alpha of the scale was found to be 0.862.
CONCLUSIONS: The CIPEAS was found to be a valid and reliable assessment tool.
CONCLUSIONS: The Critically Ill Patient Eye Assessment Scale is a valid and reliable tool for Turkish society for assessing the risk of ocular complications. It is recommended for various national and international studies with different patients in intensive care units.
摘要：
背景：眼部护理和眼部评估对于重症监护患者预防干眼和角膜擦伤等眼部并发症至关重要。然而,没有为重症监护患者开发的测量工具来检查眼部并发症的风险.
目的：本研究旨在开发一种有效可靠的工具，危重患者眼部评估量表（CIPEAS），评估眼部并发症的风险并确定眼部护理的频率。
方法：本研究为仪器开发研究。这项方法学研究是在2022年3月至2023年3月期间在土耳其对151名重症监护患者进行的。使用患者信息表和CIPEAS收集数据。采用SPSS23统计软件对数据进行评价。AMOS21用于验证用CFA获得的结构。进行了探索和验证性因素分析，以确定量表的因子结构。
结果：作为探索性因素分析的结果，获得了由一维组成的六项尺度，解释总方差的59.993%。量表的拟合指数为χ2/SD=2.653，GFI=0.954，RMSEA=0.075，NFI=0.949，CFI=0.967。Cronbach的规模的α被发现是0.862。
结论：TheCIPEAS被发现是一种有效和可靠的评估工具。
结论：危重病患者眼部评估量表是土耳其社会评估眼部并发症风险的有效且可靠的工具。建议在重症监护病房对不同患者进行各种国家和国际研究。
目的：本研究旨在开发一种有效可靠的工具，危重患者眼部评估量表（CIPEAS），评估眼部并发症的风险并确定眼部护理的频率。
方法：本研究为仪器开发研究。这项方法学研究是在2022年3月至2023年3月期间在土耳其对151名重症监护患者进行的。使用患者信息表和CIPEAS收集数据。采用SPSS23统计软件对数据进行评价。AMOS21用于验证用CFA获得的结构。进行了探索和验证性因素分析，以确定量表的因子结构。
结果：作为探索性因素分析的结果，获得了由一维组成的六项尺度，解释总方差的59.993%。量表的拟合指数为χ2/SD=2.653，GFI=0.954，RMSEA=0.075，NFI=0.949，CFI=0.967。Cronbach的规模的α被发现是0.862。
结论：TheCIPEAS被发现是一种有效和可靠的评估工具。
结论：危重病患者眼部评估量表是土耳其社会评估眼部并发症风险的有效且可靠的工具。建议在重症监护病房对不同患者进行各种国家和国际研究。
